FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology. Method of treating or preventing heart failure in a subject having a pulmonary disease involves administering to the subject a therapeutically effective amount of a composition comprising recovered mitochondria or a combined mitochondrial agent.
EFFECT: invention provides safe and effective treatment or prevention of heart failure in pulmonary diseases affecting right heart function by delivering mitochondria to patient's tissue.
9 cl, 22 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT FOR THE TREATMENT OF CARDIOMYOPATHY, PREVIOUS MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE | 2018 |
|
RU2795320C2 |
| REGULATION OF METABOLISM USING MIR-378 | 2011 |
|
RU2585491C2 |
| INHIBITOR OF PRODUCTION OF OXYGEN REACTIVE FORMS FOR TREATMENT OF DISEASES ASSOCIATED WITH FREE OXYGEN RADICALS | 2016 |
|
RU2775597C2 |
| COMPOSITIONS COMPRISING SELENIUM AND USE OF SAME FOR THE TREATMENT AND PREVENTION OF DISEASE OR CONDITIONS ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION | 2014 |
|
RU2663127C2 |
| METHOD FOR PREVENTING THE DEVELOPMENT OF MYOCARDIAL INFARCTION IN MICE WITH MELANOMA THAT DEVELOPED AGAINST THE BACKGROUND OF CHRONIC NEUROGENIC PAIN | 2022 |
|
RU2786322C1 |
| METHODS FOR TREATMENT OF HEART FAILURE AND ISCHEMIC-REPERFUSION INJURY OF HEART | 2017 |
|
RU2767445C2 |
| APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
| TREATMENT OF HEART FAILURE IN HUMANS | 2020 |
|
RU2811365C2 |
| ADVANCED COMPOUND FOR THE TREATMENT OF HEART FAILURE | 2018 |
|
RU2794975C2 |
| PROLONGED RELEASE OF NEUREGULIN FOR IMPROVEMENT IN CARDIAC FUNCTION | 2006 |
|
RU2457854C2 |
